These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 35745806)

  • 1. Increased/Targeted Brain (Pro)Drug Delivery via Utilization of Solute Carriers (SLCs).
    Huttunen J; Adla SK; Markowicz-Piasecka M; Huttunen KM
    Pharmaceutics; 2022 Jun; 14(6):. PubMed ID: 35745806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The solute carrier transporters and the brain: Physiological and pharmacological implications.
    Hu C; Tao L; Cao X; Chen L
    Asian J Pharm Sci; 2020 Mar; 15(2):131-144. PubMed ID: 32373195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacoproteomics of Brain Barrier Transporters and Substrate Design for the Brain Targeted Drug Delivery.
    Huttunen KM; Terasaki T; Urtti A; Montaser AB; Uchida Y
    Pharm Res; 2022 Jul; 39(7):1363-1392. PubMed ID: 35257288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-Type Amino Acid Transporter 1 Enables the Efficient Brain Delivery of Small-Sized Prodrug across the Blood-Brain Barrier and into Human and Mouse Brain Parenchymal Cells.
    Montaser AB; Järvinen J; Löffler S; Huttunen J; Auriola S; Lehtonen M; Jalkanen A; Huttunen KM
    ACS Chem Neurosci; 2020 Dec; 11(24):4301-4315. PubMed ID: 33228353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic Study on the Use of the l-Type Amino Acid Transporter 1 for Brain Intracellular Delivery of Ketoprofen via Prodrug: A Novel Approach Supporting the Development of Prodrugs for Intracellular Targets.
    Puris E; Gynther M; de Lange ECM; Auriola S; Hammarlund-Udenaes M; Huttunen KM; Loryan I
    Mol Pharm; 2019 Jul; 16(7):3261-3274. PubMed ID: 31180686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solute carriers as drug targets: current use, clinical trials and prospective.
    Rask-Andersen M; Masuram S; Fredriksson R; Schiöth HB
    Mol Aspects Med; 2013; 34(2-3):702-10. PubMed ID: 23506903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transporter-Mediated Drug Delivery.
    Gyimesi G; Hediger MA
    Molecules; 2023 Jan; 28(3):. PubMed ID: 36770817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Niosomes decorated with dual ligands targeting brain endothelial transporters increase cargo penetration across the blood-brain barrier.
    Mészáros M; Porkoláb G; Kiss L; Pilbat AM; Kóta Z; Kupihár Z; Kéri A; Galbács G; Siklós L; Tóth A; Fülöp L; Csete M; Sipos Á; Hülper P; Sipos P; Páli T; Rákhely G; Szabó-Révész P; Deli MA; Veszelka S
    Eur J Pharm Sci; 2018 Oct; 123():228-240. PubMed ID: 30031862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-type amino acid transporter 1 utilizing prodrugs: How to achieve effective brain delivery and low systemic exposure of drugs.
    Puris E; Gynther M; Huttunen J; Petsalo A; Huttunen KM
    J Control Release; 2017 Sep; 261():93-104. PubMed ID: 28662899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of a novel microscale thermophoresis ligand-binding assay for characterization of SLC solute carriers using oligopeptide transporter PepT1 (SLC15 family) as a model system.
    Clémençon B; Lüscher BP; Hediger MA
    J Pharmacol Toxicol Methods; 2018; 92():67-76. PubMed ID: 29580877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Transporters in Future Chemotherapy.
    Huttunen J; Huttunen KM
    Chimia (Aarau); 2022 May; 76(5):454-459. PubMed ID: 38069717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organic Cation Transporter (OCT/OCTN) Expression at Brain Barrier Sites: Focus on CNS Drug Delivery.
    Betterton RD; Davis TP; Ronaldson PT
    Handb Exp Pharmacol; 2021; 266():301-328. PubMed ID: 33674914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-type amino acid transporter 1 utilizing prodrugs of ferulic acid revealed structural features supporting the design of prodrugs for brain delivery.
    Puris E; Gynther M; Huttunen J; Auriola S; Huttunen KM
    Eur J Pharm Sci; 2019 Mar; 129():99-109. PubMed ID: 30625368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advancing drug discovery through assay development: a survey of tool compounds within the human solute carrier superfamily.
    Digles D; Ingles-Prieto A; Dvorak V; Mocking TAM; Goldmann U; Garofoli A; Homan EJ; Di Silvio A; Azzollini L; Sassone F; Fogazza M; Bärenz F; Pommereau A; Zuschlag Y; Ooms JF; Tranberg-Jensen J; Hansen JS; Stanka J; Sijben HJ; Batoulis H; Bender E; Martini R; IJzerman AP; Sauer DB; Heitman LH; Manolova V; Reinhardt J; Ehrmann A; Leippe P; Ecker GF; Huber KVM; Licher T; Scarabottolo L; Wiedmer T; Superti-Furga G
    Front Pharmacol; 2024; 15():1401599. PubMed ID: 39050757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and functional annotation of solute carrier transporters: implication for drug discovery.
    Dvorak V; Superti-Furga G
    Expert Opin Drug Discov; 2023; 18(10):1099-1115. PubMed ID: 37563933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The blood-brain barrier choline transporter.
    Geldenhuys WJ; Allen DD
    Cent Nerv Syst Agents Med Chem; 2012 Jun; 12(2):95-9. PubMed ID: 22483271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of membrane transporters in drug delivery to brain tumors.
    Nies AT
    Cancer Lett; 2007 Aug; 254(1):11-29. PubMed ID: 17275180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease-Induced Modulation of Drug Transporters at the Blood-Brain Barrier Level.
    Al Rihani SB; Darakjian LI; Deodhar M; Dow P; Turgeon J; Michaud V
    Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33916769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solute carriers (SLCs) in cancer.
    El-Gebali S; Bentz S; Hediger MA; Anderle P
    Mol Aspects Med; 2013; 34(2-3):719-34. PubMed ID: 23506905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A substrate-based ontology for human solute carriers.
    Meixner E; Goldmann U; Sedlyarov V; Scorzoni S; Rebsamen M; Girardi E; Superti-Furga G
    Mol Syst Biol; 2020 Jul; 16(7):e9652. PubMed ID: 32697042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.